Gyre Therapeutics, Inc.
Status: Publicly traded
Direct answer
Gyre Therapeutics, Inc. is publicly traded on NASDAQ under the ticker GYRE.
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other...
Can you invest in Gyre Therapeutics, Inc.?
Yes. Gyre Therapeutics, Inc. trades publicly on NASDAQ as GYRE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gyre Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.